Nanocellulose Production Patents: Leaders, Trends & White Space 2026
A patent landscape analysis of nanocellulose production technology covering 322 records: filing trends, assignee concentration, IPC composition, and the most-cited foundational patents in pulp and papermaking.
Filing growth = 2021 (9 records) → 2024 (21); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 322 records in scope (CR5), not the ranked leaders only.
What the nanocellulose production patent record shows
Nanocellulose production sits at the intersection of pulp chemistry, mechanical fibrillation and, increasingly, enzymatic and microbial synthesis. The 322 records in scope span filings from pulp and paper incumbents, specialist biomaterials developers and university-linked applicants, filed across Europe, the WIPO PCT route, the United States, Canada, India and China. Patent families are the fairer unit for judging real invention volume, since a single filing programme can generate several published documents across jurisdictions.
Filing activity peaked in 2017 at 31 records and has since moved in cycles rather than a single upward or downward line; because publication lags filing by roughly 18 months, the 2025 and 2026 counts are still filling in and should not be read as a slowdown. The class mix shows a field still anchored in classical pulp and paper chemistry (D21H, D21C) rather than having fully migrated toward biotechnology-driven routes.
Let an AI agent run this analysis on your own technology
Pick a task. Every answer cites the patents behind it.
Filing trends and technology composition
Two views of the same 322-record dataset: how filing activity has moved year over year, and how records distribute across the IPC subclasses that describe the underlying technology.
Filing activity, 2015-2026
Filings peaked at 31 records in 2017, dipped, then climbed again from 9 records in 2021 to 21 in 2024 (+133%) — the most recent year with a reasonably complete publication record. 2025 and 2026 figures will rise as later-filed applications publish.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
Technology composition by IPC subclass
D21H (pulp & paper compositions, 43.5% of records) and D21C (pulp production & treatment, 38.5%) lead the field by a wide margin over polysaccharide chemistry (C08B, 25.5%), polymer compositions (C08L, 15.8%), and the smaller nanotechnology (B82Y, 10.6%), polymer processing (C08J, 9.6%), fermentation (C12P, 9.0%) and microorganism-engineering (C12N, 8.7%) classes. Because records can carry multiple classes, these shares sum to well above 100% of the 322 records.
Shares are the percentage of the 322 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Pulp & Papermaking: Nanocellulose Production Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about pulp & papermaking: nanocellulose production patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited foundational patents
US12077910B2 — Nanocellulose production co-located at a pulp and paper mill
The patent describes fractionating a bleached or unbleached pulp feedstock in the presence of an acid, a lignin solvent and water to separate cellulose-rich solids from a hemicellulose/lignin-bearing liquid, then mechanically treating the solids to generate cellulose fibrils and/or crystals. The process is designed to bolt onto an existing pulp mill rather than stand alone.Filed by GranBio Intellectual Property Holdings, LLC; published 2024-09-03.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO2009126106A1 | Method for providing a nanocellulose involving modifying cellulose fibers | 83 |
| 2 | WO2015036659A1 | Method of forming a fibrous product | 72 |
| 3 | US20170073893A1 | High efficiency production of nanofibrillated cellulose | 51 |
| 4 | US20150368441A1 | Oleophilic and hydrophobic nanocellulose materials | 36 |
| 5 | WO2015171714A1 | High efficiency production of nanofibrillated cellulose | 36 |
| 6 | US20160289893A1 | nanocellulose | 33 |
| 7 | WO2015074120A1 | nanocellulose | 32 |
| 8 | WO2017155456A1 | Method of producing shape-retaining cellulose products, and shape-retaining cellulose products therefrom | 29 |
| 9 | US20120227920A1 | Process for production of paper | 27 |
| 10 | WO2014147293A1 | Method for producing nano- and microfibrillated cellulose | 26 |
Citation counts favour older records simply because they have had more time to accumulate citations within the searched corpus — treat them as a signal of influence on the field, not a ranking of current commercial importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for strategy
Four observations that follow directly from the filing, assignee and classification data, aimed at readers deciding where to file, license or watch.
The top of the field is concentrated, the rest is fragmented
The leading assignee holds 24 records and the fifth-ranked holds 14, together with the rest of the top five accounting for 28.3% of all 322 records in scope. The top 10 combined reach 45.3%, meaning over half the field is spread across the remaining ranked leaders and a long tail of single- or few-filing entrants.
Recent growth is real, even if the latest years understate it
Filings rose from 9 records in 2021 to 21 in 2024, a +133% increase over that three-year span and the most reliable growth signal in the dataset. Because publication lags filing by roughly 18 months, 2025 and 2026 totals will continue to rise and should not yet be read as a plateau or decline.
Classical pulp chemistry still dominates over biological routes
D21H (pulp & paper compositions) and D21C (pulp production & treatment) between them touch a large majority of records, while microorganism-based synthesis (C12N) and fermentation (C12P) sit near 9% each. That gap suggests biological production routes are still a comparatively open claim space relative to mechanical and chemical fibrillation.
Europe leads filing venue, with the PCT route close behind
Europe (EPO) receives the most filings at 63, narrowly ahead of the WIPO PCT route at 56 and the United States at 55, with Canada, India and China trailing. That spread indicates applicants are pursuing broad multi-jurisdiction protection rather than concentrating on a single home market.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to pulp & papermaking: nanocellulose production patent landscape, with the prior art for and against each one.
| Assignee | Co-assignee | Shared families |
|---|---|---|
| Stora Enso Oyj | Wetend Technologies Oy | 10 |
| Innventia AB | LINDSTROM TOM | 1 |
| Innventia AB | ANKERFORS MIKAEL | 1 |
| Kemira Oyj | STENBACKA ULF | 1 |
| Kemira Oyj | JUPPO ARI | 1 |
| Maybiomass Pte Ltd | GranBio Intellectual Property Holdings, LLC | 1 |
Only 6 co-assignee pairs appear in the dataset, and the strongest pairing links just 10 shared records — most applicants in this field file alone rather than through joint ventures or research consortia.
Where to take this analysis
The dataset points to specific next steps depending on whether the goal is freedom-to-operate, licensing or new filing strategy.
Map claim scope against the top-cited patents
The five most-cited records, several tied to high-efficiency nanofibrillated cellulose production, define much of the prior art a new filing must design around. Reviewing their independent claims before drafting narrows the risk of overlap.
Explore prior art in EurekaWatch the biological-route white space
C12N and C12P classes sit well below the pulp-chemistry classes in record share, suggesting enzymatic and microbial nanocellulose production is less claim-dense than mechanical and chemical routes.
Track emerging filings in EurekaTrack the long tail of single-filing entrants
With the top 10 assignees holding only 45.3% of records, most of the field is held by smaller or first-time filers. Monitoring new entrants early can surface licensing or acquisition targets before they scale.
Set up assignee alerts in EurekaFrequently asked questions
The dataset's leading assignee holds 24 of the 322 records in scope, with the fifth-ranked holding 14 and the tenth-ranked holding 10. Together the top 5 assignees account for 28.3% of all records and the top 10 account for 45.3%, meaning over half the field is spread across a long tail of smaller filers. This concentration pattern is typical of a field with a few first-movers and many later, narrower entrants rather than a single dominant monopoly.
Filing grew from 9 records in 2021 to 21 in 2024, a +133% increase, which is the most recent period that can be treated as reliably complete. Earlier, filings peaked at 31 records in 2017 before dipping, so the trend has not moved in one straight line. Because publication typically lags filing by around 18 months, the lower counts shown for 2025 and 2026 reflect incomplete data rather than an actual slowdown, and should not be quoted as evidence of declining interest.
Pulp and paper compositions (IPC class D21H) appear in 43.5% of the 322 records, and pulp production and treatment (D21C) appears in 38.5%, making these the two largest technology clusters by a wide margin. Polysaccharide chemistry (C08B, 25.5%) and polymer compositions (C08L, 15.8%) follow. Biologically-driven routes such as fermentation (C12P) and microorganism engineering (C12N) each sit near 9%, indicating comparatively less claim density in biological production methods versus mechanical or chemical fibrillation.
US12077910B2, assigned to GranBio Intellectual Property Holdings, LLC and published 2024-09-03, claims a process that fractionates a pulp feedstock using an acid, a lignin solvent and water to split it into cellulose-rich solids and a hemicellulose/lignin liquid, then mechanically treats the solids to form cellulose fibrils or crystals. Its distinguishing feature is that the process is designed to be co-located with, or bolted onto, an existing pulp mill rather than run as a standalone plant. Anyone designing a mill-adjacent nanocellulose process should review its specific fractionation and mechanical-treatment claim language closely.
Europe, through the EPO, receives the most filings in this dataset at 63, followed closely by the WIPO PCT route at 56 and the United States at 55. Canada (25), India (17) and China (12) trail behind. The near-parity between EPO, PCT and US filings suggests most serious applicants are pursuing broad, multi-jurisdiction protection rather than filing only in a single home market.
Research Pulp & Papermaking: Nanocellulose Production Patent Landscape in depth with Eureka
Go past this page: query the whole pulp & papermaking: nanocellulose production patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.